All 39 GNOM Holdings
The GNOM ETF is a fund that invests in companies focused on gene editing and genomic research. It aims to provide exposure to innovative technology in the healthcare sector. The fund holds stocks of companies involved in genetic testing, gene therapy, and other related technologies. The goal of the GNOM ETF is to capture potential growth in the genomics industry.
**Charts show 1 year
Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
---|---|---|---|---|---|---|
1 | NTRA | Natera Inc | 11.41% | United States | $6.23b | Diagnostics & Research |
2 | SRPT | Sarepta Therapeutics Inc | 6.75% | United States | $7.29b | Biotechnology |
3 | ALNY | Alnylam Pharmaceuticals Inc | 5.91% | United States | $20b | Biotechnology |
4 | RARE | Ultragenyx | 5.02% | United States | $2.75b | Biotechnology |
5 | CRSP | Crispr Therapeutics AG | 4.78% | United States | $5.50b | Biotechnology |
6 | 1548 | Genscript Biotech Corp | 4.71% | Hong Kong | Biotechnology | |
7 | TECH | Bio-Techne Corp | 4.63% | United States | $10.07b | Biotechnology |
8 | A | Agilent Technologies Inc | 4.6% | United States | $37b | Diagnostics & Research |
9 | QGEN | Qiagen NV | 4.52% | United States | $9.31b | Diagnostics & Research |
10 | BMRN | Biomarin Pharmaceutical Inc | 4.36% | United States | $16.45b | Biotechnology |
11 | MYGN | Myriad Genetics Inc | 3.9% | United States | $1.46b | Diagnostics & Research |
12 | ARWR | Arrowhead Pharmaceuticals Inc | 3.88% | United States | $3.15b | Biotechnology |
13 | VRTX | Vertex Pharmaceuticals Inc | 3.67% | United States | $91b | Biotechnology |
14 | TXG | 10x Genomics | 3.42% | United States | $4.21b | Health Information Services |
15 | VCYT | Veracyte Inc | 3.16% | United States | $1.89b | Biotechnology |
16 | BNTX | BioNTech SE | 2.87% | United States | $24b | Biotechnology |
17 | RCKT | Rocket Pharmaceuticals Inc | 2.72% | United States | $1.77b | Biotechnology |
18 | BEAM | Beam Therapeutics Inc | 2.41% | United States | $2.15b | Biotechnology |
19 | GILD | Gilead Sciences Inc | 2.37% | United States | $94b | Drug Manufacturers-General |
20 | ILMN | Illumina Inc | 2.15% | United States | $15.54b | Diagnostics & Research |
21 | NTLA | Intellia Therapeutics Inc | 2.08% | United States | $2.73b | Biotechnology |
22 | MRNA | Moderna Inc | 2.04% | United States | $30b | Biotechnology |
23 | CDNA | Caredx Inc | 1.67% | United States | $526.01m | Diagnostics & Research |
24 | 4974 | Takara Bio Inc | 1.1% | Japan | Biotechnology | |
25 | RGNX | Regenxbio Inc | 0.94% | United States | $847.54m | Biotechnology |
26 | FLGT | Fulgent Genetics Inc | 0.84% | United States | $824.46m | Diagnostics & Research |
27 | EDIT | Editas Medicine Inc | 0.66% | United States | $729.70m | Biotechnology |
28 | STOK | Stoke Therapeutics Inc | 0.6% | United States | $177.47m | Biotechnology |
29 | PACB | Pacific Biosciences of California | 0.57% | United States | $2.11b | Medical Devices |
30 | BNGO | Bionano Genomics Inc | 0.4% | United States | $505.29m | Medical Instruments & Supplies |
31 | QURE | Uniqure NV | 0.38% | United States | $323.24m | Biotechnology |
31 | ALLO | Allogene Therapeutics Inc | 0.38% | United States | $410.37m | Biotechnology |
33 | VERV | Verve Therapeutics Inc | 0.36% | United States | $749.42m | Biotechnology |
34 | TSVT | 2 | 0.28% | United States | $69.09m | Biotechnology |
35 | CRBU | Caribou Biosciences Inc | 0.17% | United States | $346.96m | Biotechnology |
36 | BLUE | Bluebird bio Inc | 0.15% | United States | $400.37m | Biotechnology |
37 | SGMO | Sangamo Therapeutics Inc | 0.1% | United States | $64.38m | Biotechnology |
38 | NSTG | NanoString Technologies Inc | 0.02% | United States | $27.14m | Medical Instruments & Supplies |
39 | NVTA | Invitae Corp | 0.01% | United States | $140.72m | Diagnostics & Research |